Canada Markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
105.85+1.75 (+1.68%)
At close: 04:03PM EDT
106.00 +0.15 (+0.14%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close104.10
Bid105.39 x 2200
Ask106.18 x 800
Day's Range104.82 - 106.91
52 Week Range78.77 - 115.49
Avg. Volume8,751,701
Market Cap268.372B
Beta (5Y Monthly)0.37
PE Ratio (TTM)38.23
EPS (TTM)2.77
Earnings DateApr 27, 2023
Forward Dividend & Yield2.92 (2.76%)
Ex-Dividend DateMar 14, 2023
1y Target Est118.04
  • Zacks

    Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?

    Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Merck's (MRK) stock afloat in 2023.

  • Zacks

    Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study

    Data from a mid-stage study showed that Merck's (MRK) MK-7684A did not improve progression-free survival as a potential treatment for patients with metastatic non-small cell lung cancer.

  • Reuters

    UPDATE 1-Two new vaccines against bird flu effective in Dutch lab -govt

    Two vaccines tested by a Dutch veterinary research centre have proved effective against highly infectious bird flu in a first experiment conducted under a controlled environment, the Dutch government said on Friday. "Not only did the vaccines give poultry used in the lab protection against disease symptoms but they also countered the spreading of the bird flu," the government said in a statement. One vaccine was produced by France's Ceva Animal Health and the other by Germany's Boehringer Ingelheim, an official document on the Dutch government website showed.